The medical device industry faces growing pressure to align U.S. and EU regulations, with the EU’s Medical Device Regulation ...
President Trump’s 2025 executive order establishing artificial intelligence (AI) in pediatric cancer as a national priority marks a turning point in medicine. For decades, childhood cancer treatments ...
The collaboration aims to deliver real-time image processing, robotic control and cloud-enabled intelligence in a unified architecture. “By powering our visualization, control and secure cloud ...
Rejected by leading customers Physicians as customers/intermediary complicates adoption pathways. Emerges in niche/small markets Sophisticated epidemiology and real-world data allow larger initial ...
For over three decades, Sunrise Labs stood at the forefront of engineering excellence and medical innovation. Today, the company unveils its new identity: Suntra MedTech Solutions™, a bold evolution ...
Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, surveillance, and quality management to enable real-time adaptability. Artificial ...
A new EU Commission study on the Deployment of AI in Healthcare makes one thing crystal clear: AI isn’t just a buzzword, it could be the lifeline our systems desperately need. I’m a startup advisor ...
China recently opened their first-ever AI Hospital with public pilot launches in May 2025.
The MedTech industry has seen significant growth and raised expectations as it adapts to evolving healthcare needs in the wake of the COVID-19 pandemic. The industry’s ability to make technology a ...
The Problem: A Rigid, Risk-Prone Development Model The industry’s heavy reliance on waterfall project management has resulted in long, siloed, and high-risk product development cycles. This model does ...
Titanium has become a vital material in modern medicine due to its strength, light weight, corrosion resistance, and exceptional biocompatibility with high long-term success rates and minimal risk of ...
Evolving regulations and market requirements have kept medtech companies on their toes for years. EU MDR, for example, has been a top priority and now, more companies are moving toward EU MDR ...